Alteration in gene expression profile and biological behavior in human lung cancer cell line NL9980 by nm23-H1 gene silencing

Biochemical and Biophysical Research Communications

Volumn 371, Issue 3, 2008, Pages 425-430

  Ma, Wei ^a,b   Chen, Jun ^a,b   Xue, Xingyang ^a   Wang, Zhuomin ^a   Liu, Hongyu ^b   Wang, Ting ^a   Bai, Yun ^b   Tang, Shou Ching ^c   Zhou, Qinghua ^a,b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Lung cancer; Metastasis suppressor gene; NL9980 cell line; nm23 H1

Indexed keywords

CENTRIN; CENTRIN 2; CHEMOKINE; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; CYSTATIN B; GELATINASE A; INTERSTITIAL COLLAGENASE; PLASMINOGEN ACTIVATOR INHIBITOR 2; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR SLUG; UVOMORULIN;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE S PHASE; CELL FUNCTION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SILENCING; HUMAN; HUMAN CELL; LUNG CANCER; MICROARRAY ANALYSIS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 43749094970     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.04.083     Document Type: Article

References (27)

1. Steeg P.S., Bevilacqua G., Kopper L., Thorgeirsson U.P., Talmadge J.E., Liotta L.A., and Sobel M.E. Evidence for a novel gene associated with low tumor metastatic potential. J. Natl. Cancer Inst. 80 (1988) 200-204
2. Lombardi D., and Mileo A.M. Protein interactions provide new insight into Nm23/nucleoside diphosphate kinase functions. J. Bioenerg. Biomembr. 35 (2003) 67-71
3. Roymans D., Willems R., Vissenberg K., De Jonghe C., Grobben B., Claes P., Lascu I., Van Bockstaele D., Verbelen J.P., Van Broeckhoven C., and Slegers H. Nucleoside diphosphate kinase beta (Nm23-R1/NDPKbeta) is associated with intermediate filaments and becomes upregulated upon cAMP-induced differentiation of rat C6 glioma. Exp. Cell Res. 261 (2000) 127-138
4. Bernardini G., Ribatti D., Spinetti G., Morbidelli L., Ziche M., Santoni A., Capogrossi M.C., and Napolitano M. Analysis of the role of chemokines in angiogenesis. J. Immunol. Methods 273 (2003) 83-101
5. Zhou Q.H., Wang Y.P., Che G.W., Zhu W., Chen X.H., Chen X.F., and Sun Z.L. Establishment and their biological characteristics of clonal cell subpopulations (NL9980 and L9981) from a human lung large cell carcinoma cell line (WCQH-9801). Chin. J. Lung Cancer 6 (2003) 464-468
6. Che G., Chen J., Liu L., Wang Y., Li L., Qin Y., and Zhou Q. Transfection of nm23-H1 increased expression of beta-catenin, E-cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981. Neoplasma 53 (2006) 530-537
7. Fire A. RNA-triggered gene silencing. Trends Genet. 15 (1999) 358-363
8. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
9. Kim J.H., Skates S.J., Uede T., Wong K.K., Schorge J.O., Feltmate C.M., Berkowitz R.S., Cramer D.W., and Mok S.C. Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA 287 (2002) 1671-1679
10. Uriguen L., Arteta D., Diez-Alarcia R., Ferrer-Alcon M., Diaz A., Pazos A., and Meana J.J. Gene expression patterns in brain cortex of three different animal models of depression. Genes Brain Behav. (2008)
11. Salerno M., Palmieri D., Bouadis A., Halverson D., and Steeg P.S. Nm23-H1 metastasis suppressor expression level influences the binding properties, stability, and function of the kinase suppressor of Ras1 (KSR1) Erk scaffold in breast carcinoma cells. Mol. Cell. Biol. 25 (2005) 1379-1388
12. Du J., and Hannon G.J. The centrosomal kinase Aurora-A/STK15 interacts with a putative tumor suppressor NM23-H1. Nucleic Acids Res. 30 (2002) 5465-5475
13. Leone A., Flatow U., VanHoutte K., and Steeg P.S. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 8 (1993) 2325-2333
14. Foda H.D., and Zucker S. Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis. Drug Discov. Today 6 (2001) 478-482
15. Fang J., Shing Y., Wiederschain D., Yan L., Butterfield C., Jackson G., Harper J., Tamvakopoulos G., and Moses M.A. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc. Natl. Acad. Sci. USA 97 (2000) 3884-3889
16. Vihinen P., and Kahari V.M. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int. J. Cancer 99 (2002) 157-166
17. Nakopoulou L., Tsirmpa I., Alexandrou P., Louvrou A., Ampela C., Markaki S., and Davaris P.S. MMP-2 protein in invasive breast cancer and the impact of MMP-2/TIMP-2 phenotype on overall survival. Breast Cancer Res. Treat. 77 (2003) 145-155
18. Shiraishi T., Mori M., Tanaka S., Sugimachi K., and Akiyoshi T. Identification of cystatin B in human esophageal carcinoma, using differential displays in which the gene expression is related to lymph-node metastasis. Int. J. Cancer 79 (1998) 175-178
19. Cervoni L., Egistelli L., Eufemi M., d'Abusco A.S., Altieri F., Lascu I., Turano C., and Giartosio A. DNA sequences acting as binding sites for NM23/NDPK proteins in melanoma M14 cells. J. Cell. Biochem. 98 (2006) 421-428
20. Morgunova E., Tuuttila A., Bergmann U., Isupov M., Lindqvist Y., Schneider G., and Tryggvason K. Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. Science 284 (1999) 1667-1670
21. Thoreson M.A., and Reynolds A.B. Altered expression of the catenin p120 in human cancer: implications for tumor progression. Differentiation 70 (2002) 583-589
22. Hunt N.C., Douglas-Jones A.G., Jasani B., Morgan J.M., and Pignatelli M. Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas. Virchows Arch. 430 (1997) 285-289
23. Batlle E., Sancho E., Franci C., Dominguez D., Monfar M., Baulida J., and Garcia De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2 (2000) 84-89
24. Li A., Dubey S., Varney M.L., Dave B.J., and Singh R.K. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J. Immunol. 170 (2003) 3369-3376
25. Jodele S., Blavier L., Yoon J.M., and DeClerck Y.A. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev. 25 (2006) 35-43
26. Fischbach M.A., and Settleman J. Specific biochemical inactivation of oncogenic Ras proteins by nucleoside diphosphate kinase. Cancer Res. 63 (2003) 4089-4094
27. Rennekampff H.O., Hansbrough J.F., Woods Jr. V., Dore C., Kiessig V., and Schroder J.M. Role of melanoma growth stimulatory activity (MGSA/gro) on keratinocyte function in wound healing. Arch. Dermatol. Res. 289 (1997) 204-212